Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2003 1
2005 6
2006 1
2007 4
2008 4
2009 3
2010 1
2011 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A. Marzocchi A, et al. Among authors: maresta a. Circulation. 2007 Jun 26;115(25):3181-8. doi: 10.1161/CIRCULATIONAHA.106.667592. Epub 2007 Jun 11. Circulation. 2007. PMID: 17562952
Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry.
Balducelli M, Ortolani P, Marzaroli P, Piovaccari G, Menozzi A, Manari A, Sangiorgio P, Tarantino F, Rossi R, Maresta A, Tondi S, Passerini F, Guastaroba P, Grilli R, Marzocchi A. Balducelli M, et al. Among authors: maresta a. Catheter Cardiovasc Interv. 2010 Feb 15;75(3):327-34. doi: 10.1002/ccd.22293. Catheter Cardiovasc Interv. 2010. PMID: 19937776
Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry.
Ortolani P, Balducelli M, Marzaroli P, Piovaccari G, Menozzi A, Guiducci V, Sangiorgio P, Tarantino F, Geraci G, Castriota F, Tondi S, Saia F, Cooke RM, Guastaroba P, Grilli R, Marzocchi A, Maresta A. Ortolani P, et al. Among authors: maresta a. Circulation. 2008 Feb 19;117(7):923-30. doi: 10.1161/CIRCULATIONAHA.107.730416. Epub 2008 Feb 4. Circulation. 2008. PMID: 18250265
Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events.
Marzocchi A, Piovaccari G, Manari A, Aurier E, Benassi A, Saia F, Casella G, Varani E, Santarelli A, Guastaroba P, Grilli R, Maresta A. Marzocchi A, et al. Among authors: maresta a. Am J Cardiol. 2005 Jun 15;95(12):1409-14. doi: 10.1016/j.amjcard.2005.01.096. Am J Cardiol. 2005. PMID: 15950561
Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry.
Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, Maresta A, Barlocco F, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Patti A, De Servi S. Tamburino C, et al. Among authors: maresta a. Eur Heart J. 2009 May;30(10):1171-9. doi: 10.1093/eurheartj/ehp052. Epub 2009 Mar 10. Eur Heart J. 2009. PMID: 19276194
24 results